Temozolomide (TMZ) and radiation therapy (RT) combination in elderly patients with glioblastoma: A multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).

被引:0
|
作者
Lombardi, Giuseppe
Pace, Andrea
Pasqualetti, Francesco
Rizzato, Simona
Faedi, Marina
Anghileri, Elena
Nicolotto, Elisa
Bazzoli, Elena
Bellu, Luisa
Villani, Veronica
Fabi, Alessandra
Ferrazza, Patrizia
Gurrieri, Lorena
Dall'Agata, Monia
Eoli, Marica
Della Puppa, Alessandro
Pambuku, Ardi
D'Avella, Domenico
Ruda, Roberta
Zagonel, Vittorina
机构
[1] Veneto Inst Oncol IRCCS, Med Oncol 1, Dept Clin & Expt Oncol, Padua, Italy
[2] Regina Elena Inst Canc Res, Neurooncol Unit, Rome, Italy
[3] Azienda Osped Univ Pisana, Dept Radiotherapy, Pisa, Italy
[4] Azienda Osped Univ Udine, Dept Oncol, Udine, Italy
[5] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Dept Med Oncol, Meldola, Italy
[6] Fdn IRCCS Ist Neurol C Besta, Unit Mol Neurooncol, Milan, Italy
[7] Univ Turin, Dept Neurooncol, Turin, Italy
[8] City Hlth & Sci, Turin, Italy
[9] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy
[10] Ctr S Giovanni di Dio Fatebenefratelli, IRCCS, Brescia, Italy
[11] Regina Elena Inst Canc Res, Div Med Oncol, Rome, Italy
[12] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Biostat & Clin Trials Unit, Meldola, Italy
[13] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[14] Azienda Osped Padova, Dept Neurosurg, Padua, Italy
[15] Univ Padua, Dept Neurosurg, Padua, Italy
关键词
D O I
10.1200/jco.2015.33.15_suppl.e13003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13003
引用
收藏
页数:1
相关论文
共 50 条
  • [31] DO PATIENTS WITH MOLECULARLY-DEFINED GLIOBLASTOMA SHARE THE SAME CLINICAL CHARACTERISTICS AND OUTCOME OF HISTOLOGICALLY-DEFINED GLIOBLASTOMA? A MULTICENTRIC STUDY FROM THE ITALIAN ASSOCIATION OF NEURO-ONCOLOGY (AINO)
    Bruno, F.
    Pellerino, A.
    Bertero, L.
    Silvani, A.
    Pollo, B.
    Ius, T.
    Pizzolitto, S.
    Conti Nibali, M.
    Berzero, G.
    Navarria, P.
    Gurrieri, L.
    Di Stefano, A.
    Maccari, M.
    Lombardi, G.
    Interno, V
    Pronello, E.
    Caffo, M.
    D'Alessandris, Q.
    Soffietti, R.
    Garbossa, D.
    Bello, L.
    Ruda, R.
    NEURO-ONCOLOGY, 2024, 26 : V9 - V10
  • [32] Prognostic factors in glioblastoma patients treated with the nitrosourea fotemustine at first relapse after the Stupp regimen: results from the GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)
    Santoni, M.
    Lombardi, G.
    Scoccianti, S.
    Fabrini, M. G.
    Silvani, A.
    Villani, V.
    Marinelli, A.
    Lolli, I.
    Balducci, M.
    Arcicasa, M.
    Salvati, M.
    Sponghini, A. P.
    Vallarelli, S.
    Caroli, M.
    Imbesi, F.
    Bilancia, D.
    Faedi, M.
    Cascinu, S.
    Soffietti, R.
    Ruda, R.
    ANNALS OF ONCOLOGY, 2015, 26 : 133 - 133
  • [33] A PHASE II STUDY OF AINO (ITALIAN ASSOCIATIONOF NEURO-ONCOLOGY) ON BEVACIZUMAB AND FOTEMUSTINE FOR RECURRENT GLIOBLASTOMA: OUTCOME, PATTERNS OF RELAPSE AND SALVAGE TREATMENTS
    Trevisan, E.
    Bertero, L.
    Cassoni, P.
    Morra, I.
    Pasqualetti, F.
    Lolli, I.
    Castiglione, A.
    Ciccone, G.
    Ruda, R.
    Soffietti, R.
    NEURO-ONCOLOGY, 2014, 16
  • [34] GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology): Analysis of factors influencing survival in glioblastoma patients receiving the nitrosourea fotemustine at first relapse following Stupp regimen.
    Ruda, Roberta
    Lombardi, Giuseppe
    Scoccianti, Silvia
    Fabrini, Maria Grazia
    Santoni, Matteo
    Pace, Andrea
    Silvani, Antonio
    Marinelli, Alfredo
    Lolli, Ivan
    Balducci, Mario
    Arcicasa, Mauro
    Salvati, Maurizio
    Sponghini, Andrea
    Vallarelli, Simona
    Caroli, Manuela
    Imbesi, Francesca
    Bilancia, Domenico
    Faedi, Marina
    Cascinu, Stefano
    Soffietti, Riccardo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] GLIOSTRY (GLIOBLASTOMA REGISTRY) OF THE AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY): FINAL ANALYSIS OF FACTORS INFLUENCING SURVIVAL IN GLIOBLASTOMA PATIENTS RECEIVING THE NITROSOUREA FOTEMUSTINE AT FIRST PROGRESSION FOLLOWING CHEMORADIATION.
    Ruda, R.
    Lombardi, G.
    Scoccianti, S.
    Pasqualetti, F.
    Silvani, A.
    Pace, A.
    Arcicasa, M.
    Salvati, M.
    Caroli, M.
    Soffietti, R.
    NEURO-ONCOLOGY, 2016, 18 : 48 - 48
  • [36] Phase II trial of dose-dense temozolomide as initial treatment for progressive low-grade oligodendroglial tumors: A multicentric study of the Italian Association of Neuro-Oncology (AINO)
    Ruda, Roberta
    Bertero, Luca
    Trevisan, Elisa
    Pace, Andrea
    Carapella, Carmine Maria
    Dealis, Cristina
    Caroli, Manuela
    Faedi, Marina
    Bomprezzi, Chiara
    Soffietti, Riccardo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology)
    Scoccianti, Silvia
    Magrini, Stefano Maria
    Ricardi, Umberto
    Detti, Beatrice
    Krengli, Marco
    Parisi, Salvatore
    Bertoni, Filippo
    Sotti, Guido
    Cipressi, Samantha
    Tombolini, Vincenzo
    Dall'Oglio, Stefano
    Lioce, Marco
    Saieva, Calogero
    Buglione, Michela
    Mantovani, Cristina
    Rubino, Giovanni
    Muto, Paolo
    Fusco, Vincenzo
    Fariselli, Laura
    de Renzis, Costantino
    Masini, Laura
    Santoni, Riccardo
    Pirtoli, Luigi
    Biti, Giampaolo
    NEURO-ONCOLOGY, 2012, 14 (06) : 798 - 807
  • [38] NCCTG phase I trial of temsirolimus (CCI-779) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients
    Sarkaria, J. N.
    Galanis, E.
    Wu, W.
    Giannini, C.
    Jaeckle, K. A.
    Doyle, L.
    Uhm, J.
    Brown, P.
    Dietz, A. B.
    Buckner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Retrospective analysis of glioblastoma multiforme (GBM) patients treated initially with BCNU compared to temozolomide (TMZ) with concomitant radiation therapy
    Vinjamuri, M.
    Adumala, R.
    Altaha, R.
    Hobbs, J.
    Crowell, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] PHASE II AND PHARMACOGENOMICS (PGX) STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
    Butowski, Nicholas A.
    Lamborn, Kathleen L.
    Polley, Mei-Yin C.
    Hsieh, Emily
    Kivett, Valerie
    Page, Margaretta S.
    Parvataneni, Rupa
    Nicol, Steve
    Thornton, Don
    Prados, Michael
    NEURO-ONCOLOGY, 2009, 11 (05) : 621 - 621